Mouse IL-2 FlowCytomix Simplex

Also known as: Aldesleukin, T cell growth factor, TCGF

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS8601FF*

Cat. No. Size
BMS8601FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Mouse IL-2 FlowCytomix Simplex.

Click on image to view more information.

  • Data for Mouse IL-2 FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Mouse IL-2 in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Mouse Basic Kit (cat. BMS8440FF), this kit can be used to detect IL-2 alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population A6.

Interleukin-2 (IL-2) plays a central role in the activation and proliferation of lymphocytes that have been primed by antigens. IL-2 plays a pivotal role in for the expansion of most T-cells, natural killer cells and B-cells during certain phases of their response.
IL-2 gene expression is regulated at the transcriptional level by several activation pathways. Antigen-specific proliferation of helper and cytotoxic T-lymphocytes following stimulation is critically dependent on IL-2 expression, secretion, and binding to receptors for IL-2 induced in an autocrine fashion on the surface of T-cells.

Apart from its most important role to mediate antigen-specific T-lymphocyte proliferation, IL-2 modulates the expression of interferon-gamma and major histocompatibility antigens, stimulates proliferation and differentiation of activated B-cells, augments natural killer cell activity and inhibits granulocyte-macrophage colony formation. Alterations in the ability of T-cells to synthesize IL-2 have been observed in physiologic and pathologic states.

Details
Reactivity Mouse
Sample Volume 25 uL
Suitable Sample Types cell culture supernatant, serum
Sensitivity 8.8 pg/mL
Standard Curve Range 27 - 20,000 pg/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with monoclonal antibody to mouse IL-2, Bead Population A6
2 vials mouse IL-2 Standard (lyophilized): 400 ng/ml upon reconstitution
1 vial (350 ul) Biotin-Conjugate (20x) anti- mouse IL-2 monoclonal antibody
Reported Applications Multiplex Immunoassay
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
BMS212/2* Human sIL-2R Platinum ELISA ELISA RUO
BMS6004* Mouse IL-12 p70 Platinum ELISA ELISA RUO
BMS607/2INST* Mouse TNF-alpha Instant ELISA ELISA RUO
BMS86027FF* Mouse IFN-alpha FlowCytomix Simplex Multiplex RUO
References

Citations: Wirtz,Stefan; Tubbe,Ingrid; Galle,Peter R.; Schild,Hans J.; Birkenbach,Mark; Blumberg,Richard S.; Neurath,Markus F.. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. Journal of Experimental Medicine 2006;203:1875-1881. (Link)

Romano M,D'Souza S,Adnet PY,Laali R,Jurion F,Palfliet K,Huygen K.. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.. Vaccine 2006;24:4640-4643. (Link)

O'Connor,Richard A.; Prendergast,Catriona T.; Sabatos,Catherine A.; Lau,Clement W.Z.; Leech,Melanie D.; Wraith,David C.; Anderton,Stephen M.. Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 2008;181:3750-3754. (Link)

Raveney,Ben J.E.; Richards,Claire; Aknin,Marie Laure; Copland,David A.; Burton,Bronwen R.; Kerr,Emma; Nicholson,Lindsay B.; Williams,Neil A.; Dick,Andrew D.. The B Subunit of Escherichia coli Heat-Labile Enterotoxin Inhibits Th1 but Not Th17 Cell Responses in Established Experimental Autoimmune Uveoretinitis. Investigative Ophthalmology & Visual Science 2008;49:4008-4017. (Link)

Cuesta,Angel M.; Suarez,Eduardo; Larsen,Martin; Jensen,Kim Bak; Sanz,Laura; Compte,Marta; Kristensen,Peter; varez-Vallina,Luis. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 2006;117:502-506. (Link)

Brignole,C.; Marimpietri,D.; Pastorino,F.; Di,Paolo D.; Pagnan,G.; Loi,M.; Piccardi,F.; Cilli,M.; Tradori-Cappai,A.; Arrigoni,G.; Pistoia,V.; Ponzoni,M.. Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides. J Control Release 2009;(Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

Neves,S.; Faneca,H.; Bertin,S.; Konopka,K.; Duzgunes,N.; Pierrefite-Carle,V.; Simoes,S.; Pedroso de Lima,M.. Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response. Cancer Gene Ther 2009;16:91-101. (Link)

Leppkes,Moritz; Becker,Christoph; Ivanov,Ivaylo I.; Hirth,Sebastian; Wirtz,Stefan; Neufert,Clemens; Pouly,Sandrine; Murphy,Andrew J.; Valenzuela,David M.; Yancopoulos,George D.; Becher,Burkhard; Littman,Dan R.; Neurath,Markus F.. RORgamma expressing Th17 cells drive chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136:257-267. (Link)

Thomas,Ian J.; Petrich de Marquesini,Liliana G.; Ravanan,Rommel; Smith,Richard M.; Guerder,Sylvie; Flavell,Richard A.; Wraith,David C.; Wen,Li; Wong,F.Susan. CD86 Has Sustained Costimulatory Effects on CD8 T Cells. The Journal of Immunology 2007;179:5936-5946. (Link)

Ataman-™nal,Y.; Munier,S.; Ganee,A.; Terrat,C.; Durand,P.Y.; Battail,N.; Martinon,F.; Le,Grand R.; Charles,M.H.; Delair,T.; Verrier,B.. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 2006;112:175-185. (Link)

Ganta,Roman R.; Cheng,Chuanmin; Miller,Elizabeth C.; McGuire,Bridget L.; Peddireddi,Lalitha; Sirigireddy,Kamesh R.; Chapes,Stephen K.. Differential Clearance and Immune Responses to Tick Cell vs. Macrophage Culture-Derived Ehrlichia chaffeensis in Mice. Infection and Immunity 2006;75:135-145. (Link)

Timmers,Leo; van Keulen,J.Karlijn; Hoefer,Imo E.; Meijs,Matthijs F.L.; van Middelaar,Ben; den Ouden,Krista; van Echteld,Cees J.A.; Pasterkamp,Gerard; de Kleijn,Dominique P.V.. Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction. Circulation Research 2009;104:699-706. (Link)

Timmers L,Sluijter JP,van Keulen JK,Hoefer IE,Nederhoff MG,Goumans MJ,Doevendans PA,van Echteld CJ,Joles JA,Quax PH,Piek JJ,Pasterkamp G,de Kleijn DP.. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102:257-264. (Link)

Liu,Qi; Cheng,Lily I.; Yi,Liang; Zhu,Nannan; Wood,Adam; Changpriroa,Cattlena May; Ward,Jerrold M.; Jackson,Sharon H.. p47phox Deficiency Induces Macrophage Dysfunction Resulting in Progressive Crystalline Macrophage Pneumonia. American Journal of Pathology 2009;174:153-163. (Link)

Loser,Karin; Apelt,Jenny; Voskort,Maik; Mohaupt,Mariette; Balkow,Sandra; Schwarz,Thomas; Grabbe,Stephan; Beissert,Stefan. IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice. The Journal of Immunology 2007;179:365-371. (Link)

Hildner,K.M.; Schirmacher,P.; Atreya,I.; Dittmayer,M.; Bartsch,B.; Galle,P.R.; Wirtz,S.; Neurath,M.F.. Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J Immunol 2007;178:3427-3436. (Link)

Fletcher,Julie M.; Jordan,Margaret A.; Snelgrove,Sarah L.; Slattery,Robyn M.; Dufour,Francois D.; Kyparissoudis,Konstantinos; Besra,Gurdyal S.; Godfrey,Dale I.; Baxter,Alan G.. Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4. The Journal of Immunology 2008;181:3400-3412. (Link)

Pozdzik,A.A.; Salmon,I.J.; Husson,C.P.; Decaestecker,C.; Rogier,E.; Bourgeade,M.F.; schodt-Lanckman,M.M.; Vanherweghem,J.L.; Nortier,J.L.. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol.Dial.Transplant 2008;23:2480-2491. (Link)

Presser,Katrin; Schwinge,Dorothee; Wegmann,Michael; Huber,Samuel; Schmitt,Steffen; Quaas,Alexander; Maxeiner,Joachim H.; Finotto,Susetta; Lohse,Ansgar W.; Blessing,Manfred; Schramm,Christoph. Coexpression of TGF-{beta}1 and IL-10 Enables Regulatory T Cells to Completely Suppress Airway Hyperreactivity. The Journal of Immunology 2008;181:7751-7758. (Link)

Mrabet-Dahbi,S.; Metz,M.; Dudeck,A.; Zuberbier,T.; Maurer,M.. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp.Dermatol. 2009;18:437-444. (Link)

Claudio,Estefania; Sonder,Soren Ulrik; Saret,Sun; Carvalho,Gabrielle; Ramalingam,Thirumalai R.; Wynn,Thomas A.; Chariot,Alain; Garcia-Perganeda,Antonio; Leonardi,Antonio; Paun,Andrea; Chen,Amy; Ren,Nina Y.; Wang,Hongshan; Siebenlist,Ulrich. The Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation. The Journal of Immunology 2009;182:1617-1630. (Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

Fantini,M.C.; Becker,C.; Tubbe,I.; Nikolaev,A.; Lehr,H.A.; Galle,P.; Neurath,M.F.. Transforming growth factor {beta} induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006;55:671-680. (Link)

References: Naldini,A.; Fleischmann,W.R.,Jr.; Ballas,Z.K.; Klimpel,K.D.; Klimpel,G.R.. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation. J.Immunol. 1987;139:1880-1884. (Link)

Tigges,M.A.; Casey,L.S.; Koshland,M.E.. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786. (Link)

Gressler,V.H.; Weinkauff,R.E.; Franklin,W.A.; Golomb,H.M.. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2. Blood 1988;72:1048-1053. (Link)

Phadke,K.; Carlson,D.G.; Gitter,B.D.; Butler,L.D.. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J.Immunol. 1986;136:4085-4091. (Link)

Cornaby,A.; Simpson,M.; Vann,Rice R.; Dempsey,R.; Madras,P.; Jenkins,R.; Monaco,A.. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients. Transplant Proc. 1988;20:827-830. (Link)